MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 46 filers reported holding MILLENDO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 77 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 77 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 77 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 77 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 77 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 77 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 77 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 77 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 77 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 77 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $11,103,000 | 2.86% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $10,240,000 | 1.29% |
| Bpifrance SA | 1,078,670 | $8,575,000 | 1.10% |
| Prosight Management, LP | 256,739 | $2,041,000 | 1.05% |
| ADAMS STREET PARTNERS LLC | 459,145 | $3,285,000 | 0.69% |
| NEA Management Company, LLC | 1,766,779 | $14,046,000 | 0.56% |
| Samsara BioCapital, LLC | 45,101 | $359,000 | 0.34% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 64,794 | $515,000 | 0.23% |
| Worth Venture Partners, LLC | 25,951 | $206,000 | 0.16% |
| PA Capital LLC | 13,984 | $111,000 | 0.12% |